Universitätsklinikum Göttingen

Characterization of Checkpoint Inhibitor-associated Diabetes mellitus - Experience in 12 Patients (2018) Satzger I, Momma M, Thoms KM, Eigentler T, Schultz E, Loquai C, Zimmer L, et al. Conference contribution Dry Mouth under Immune Checkpoint Inhibitors: an Analysis of 29 Patients from 10 German Skin Cancer Centers (2018) Hensen J, Thoms KM, Kaehler K, Gutzmer R, Zimmer L, Zacher M, Alter M, et al. Conference contribution Erratum to: Requirements for a cross-location biobank IT infrastructure : Survey of stakeholder input on the establishment of a biobank network of the German Biobank Alliance (GBA) (2018) Schüttler C, Buschhueter N, Doellinger C, Ebert L, Hummel M, Linde J, Prokosch HU, et al. Journal article, Erratum Requirements for a cross-location biobank IT infrastructure : Survey of stakeholder input on the establishment of a biobank network of the German Biobank Alliance (GBA) (2018) Schüttler C, Buschhueter N, Doellinger C, Ebert L, Hummel M, Linde J, Prokosch HU, et al. Journal article Whither systems medicine? (2018) Apweiler R, Beissbarth T, Berthold MR, Bluethgen N, Burmeister Y, Dammann O, Deutsch A, et al. Journal article Neuromuscular Side Effects of Immune Checkpoint Inhibitors (2018) Moreira A, Loquai C, Knauss S, Gutzmer R, Dimitriou F, Meier F, Heppt M, et al. Conference contribution From relative to absolute treatment outcomes-Correlation of PASI 90 and PASI <= 2 in three clinical trials with secukinumab (2018) Reich K, Bachhuber T, Melzer N, Sieder C, Sticherling M Conference contribution From relative to absolute Treatment Goals - Correlation of PASI 90 and PASI <=2 in three clinical Studies with Secukinumab (2018) Reich K, Bachhuber T, Melzer N, Sieder C, Sticherling M Conference contribution Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial (2018) Kitz J, Fokas E, Beissbarth T, Stroebel P, Wittekind C, Hartmann A, Rueschoff J, et al. Journal article Successful treatment with interleukin-17A antagonists of generalized pustular psoriasis in patients without IL36RN mutations (2018) Wilsmann-Theis D, Schnell LM, Ralser-Isselstein V, Bieber T, Schoen MP, Hüffmeier U, Moessner R Journal article